Innovation to Commercialization (I2C) Program

The Innovation to Commercialization (I2C) Program retired in 2021.

It supported researchers to advance their discoveries or inventions towards practical application, resulting in products or technologies that improve health outcomes and enrich BC’s health innovation ecosystem.

The program allowed researchers to protect time to focus on improving the viability of their intellectual property and advancing discoveries or inventions towards products to improve health outcomes, benefit society and enrich the health innovation ecosystem in BC through contributing to talent development and a strong, sustainable knowledge economy.